Stoke Therapeutics, Inc.
NASDAQ:STOK
13.27 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Assets: | |||||||
Current Assets: | |||||||
Cash & Cash Equivalents
| 191.442 | 113.556 | 144.895 | 287.308 | 222.471 | 105.399 | 1.797 |
Short Term Investments
| 9.952 | 116.039 | 74.915 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 201.394 | 229.595 | 219.81 | 287.308 | 222.471 | 105.399 | 1.797 |
Net Receivables
| 0.064 | 0.588 | 0.132 | 0.006 | 0.281 | 0.196 | 0 |
Inventory
| 0 | 10.932 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 13.881 | 2.955 | 9.276 | 6.616 | 3.281 | 0.548 | 0.113 |
Total Current Assets
| 215.339 | 244.07 | 229.218 | 293.93 | 226.033 | 106.143 | 1.91 |
Non-Current Assets: | |||||||
Property, Plant & Equipment, Net
| 12.434 | 11.428 | 9.078 | 3.79 | 2.512 | 1.192 | 0.473 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0.569 | 0.569 | 0.569 | 0.205 | 0.205 | 0.204 | 0.056 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Assets
| 13.003 | 11.997 | 9.647 | 3.995 | 2.717 | 1.396 | 0.529 |
Total Assets
| 228.342 | 256.067 | 238.865 | 297.925 | 228.75 | 107.539 | 2.439 |
Liabilities & Equity: | |||||||
Current Liabilities: | |||||||
Account Payables
| 1.695 | 0.766 | 2.385 | 1.495 | 0.751 | 1.071 | 0.141 |
Short Term Debt
| 2.062 | 2.359 | 1.507 | 1.066 | 0 | 0 | 3 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 15.309 | 14.88 | 12.707 | -1.066 | 0 | 0 | -3 |
Other Current Liabilities
| 11.753 | 13.389 | 0.54 | 9.93 | 3.35 | 1.396 | 3.574 |
Total Current Liabilities
| 30.819 | 31.394 | 17.139 | 11.425 | 4.101 | 2.467 | 3.715 |
Non-Current Liabilities: | |||||||
Long Term Debt
| 4.773 | 2.717 | 3.532 | 0.08 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 33.074 | 36.856 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| -4.773 | -2.717 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 4.884 | 2.968 | 0.417 | 0.342 | 0.221 | 0.004 | 0.016 |
Total Non-Current Liabilities
| 37.958 | 39.824 | 3.949 | 0.422 | 0.221 | 0.004 | 0.016 |
Total Liabilities
| 68.777 | 71.218 | 21.088 | 11.847 | 4.322 | 2.471 | 3.731 |
Equity: | |||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0.002 | 0.005 |
Common Stock
| 0.005 | 0.004 | 0.004 | 0.004 | 0.003 | 0.001 | 0.001 |
Retained Earnings
| -401.849 | -297.15 | -196.083 | -110.278 | -58.035 | -25.71 | -13.189 |
Accumulated Other Comprehensive Income/Loss
| -0.024 | -1.175 | -0.168 | -0 | 0 | -0.379 | -0.172 |
Other Total Stockholders Equity
| 561.433 | 483.17 | 414.024 | 396.352 | 282.46 | 131.154 | 12.063 |
Total Shareholders Equity
| 159.565 | 184.849 | 217.777 | 286.078 | 224.428 | 105.068 | -1.292 |
Total Equity
| 159.565 | 184.849 | 217.777 | 286.078 | 224.428 | 105.068 | -1.292 |
Total Liabilities & Shareholders Equity
| 228.342 | 256.067 | 238.865 | 297.925 | 228.75 | 107.539 | 2.439 |